Switching to Ozempic® from another GLP-1 RA significantly reduced blood sugar and weight in people with type 2 diabetes in routine clinical practice

NEXT STORY
Lexicon Pharmaceuticals Presents Clinical Data at 80th American Diabetes Association Scientific Sessions
PREV STORY
vTv Therapeutics Presents Two Late-Breaking Poster Sessions on Simplici-T1 Study at the American Diabetes Association’s Virtual Sessions Supporting the Potential of TTP399 as First-in-Class Oral Adjunctive Therapy for Type 1 Diabetes Patients
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Rhythm Pharmaceuticals Receives Positive CHMP Opinion for Setmelanotide for Treatment of Obesity and Control of Hunger Associated with POMC, PCSK1 and LEPR Deficiency

author_avatar
NASDAQ Market News

Barbara Ann Karmanos Cancer Institute receives 2018 Women’s Choice Award® as one of America’s Best Hospitals for Cancer Care & Research

DETROIT, Jan. 23, 2018 (GLOBE NEWSWIRE) -- The Barbara Ann Karmanos Cancer Institute has ...

author_avatar
NASDAQ Market News

Roche completed the repurchase of Roche shares from Novartis

author_avatar
NASDAQ Market News